Percheron Therapeutics Ltd
ASX:PER

Watchlist Manager
Percheron Therapeutics Ltd Logo
Percheron Therapeutics Ltd
ASX:PER
Watchlist
Price: 0.009 AUD Market Closed
Market Cap: AU$9.8m

Cash Flow Statement

Cash Flow Statement
Percheron Therapeutics Ltd

Rotate your device to view
Cash Flow Statement
Currency: AUD
Jun-2003 Dec-2003 Jun-2004 Dec-2004 Jun-2005 Dec-2005 Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025
Operating Cash Flow
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
1
0
0
0
0
0
0
1
2
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
Change in Working Capital
0
1
2
1
1
1
0
0
0
1
2
6
4
2
2
1
1
0
0
0
1
2
1
1
5
5
2
1
1
1
0
0
0
1
1
1
1
0
1
2
2
1
2
4
3
Cash from Operating Activities
(7)
N/A
(4)
+38%
(2)
+49%
(5)
-125%
(6)
-12%
(4)
+31%
(4)
-2%
(3)
+20%
(3)
+15%
(3)
-30%
(3)
+3%
(3)
+17%
(3)
-17%
(2)
+28%
(1)
+43%
(2)
-24%
(2)
-13%
(2)
-32%
(2)
+2%
(3)
-17%
(3)
-1%
(2)
+34%
(3)
-65%
(3)
+4%
1
N/A
0
-64%
(2)
N/A
(2)
+8%
(3)
-57%
(3)
+11%
(2)
+11%
(3)
-20%
(3)
-6%
(3)
-1%
(4)
-33%
(4)
-10%
(6)
-34%
(8)
-30%
(8)
-3%
(7)
+13%
(8)
-20%
(10)
-27%
(10)
+2%
(14)
-37%
(16)
-13%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
(0)
(0)
0
0
0
(0)
(0)
(0)
(0)
0
0
(0)
(0)
0
(0)
(0)
0
(0)
(0)
(0)
0
0
0
(0)
(0)
(0)
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
0
2
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
(0)
N/A
(0)
N/A
(0)
N/A
(0)
N/A
(0)
+50%
0
N/A
0
N/A
0
N/A
(0)
N/A
(0)
N/A
(0)
N/A
(0)
N/A
0
N/A
0
N/A
(0)
N/A
(0)
N/A
0
N/A
(0)
N/A
(0)
N/A
0
N/A
(0)
N/A
(0)
-100%
(0)
+50%
0
N/A
0
N/A
0
N/A
(0)
N/A
(0)
-413%
(0)
+22%
0
N/A
(2)
N/A
0
N/A
2
N/A
0
N/A
(0)
N/A
(0)
-59%
(0)
+49%
(0)
+74%
(0)
-77%
(0)
-582%
(0)
-10%
(0)
+55%
(0)
+73%
(0)
-19%
(0)
-67%
Financing Cash Flow
Net Issuance of Common Stock
5
10
10
0
0
0
4
6
2
0
2
0
0
0
0
2
2
1
6
7
2
1
1
2
4
3
0
0
0
(0)
5
0
2
5
5
10
9
23
23
0
0
12
12
15
15
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other
(0)
(0)
(0)
0
0
0
(0)
(0)
(0)
0
(0)
0
0
0
0
(0)
0
(0)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
0
(0)
0
(0)
(0)
(0)
(1)
(1)
(1)
(1)
0
0
(1)
(1)
(1)
(1)
Cash from Financing Activities
4
N/A
10
+139%
10
+1%
0
N/A
0
N/A
0
N/A
3
N/A
5
+61%
2
-62%
0
N/A
2
N/A
0
N/A
0
N/A
0
N/A
0
N/A
2
N/A
2
+22%
1
-63%
5
+455%
6
+27%
2
-71%
0
-75%
0
-2%
2
+267%
4
+156%
3
-39%
0
N/A
0
N/A
0
-38%
(0)
N/A
5
N/A
0
N/A
2
N/A
5
+239%
5
-2%
9
+82%
8
-16%
21
+169%
21
+0%
(0)
N/A
(0)
-25%
11
N/A
11
+1%
14
+27%
14
-1%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Change in Cash
(3)
N/A
6
N/A
8
+39%
(5)
N/A
(6)
-12%
(4)
+31%
(1)
+85%
2
N/A
(1)
N/A
(4)
-447%
(1)
+65%
(1)
+48%
(3)
-405%
(2)
+28%
(1)
+43%
0
N/A
1
+69%
(2)
N/A
3
N/A
4
+38%
(1)
N/A
(1)
-50%
(3)
-85%
(1)
+49%
5
N/A
3
-45%
(2)
N/A
(2)
+10%
(3)
-58%
(3)
+9%
(0)
+100%
2
N/A
1
-48%
2
+122%
1
-48%
5
+325%
2
-60%
13
+585%
13
-2%
(7)
N/A
(8)
-20%
1
N/A
1
+58%
0
-78%
(2)
N/A
Free Cash Flow
Free Cash Flow
(7)
N/A
(4)
+38%
(2)
+49%
(5)
-124%
(6)
-12%
(4)
+31%
(4)
-2%
(3)
+20%
(3)
+15%
(4)
-30%
(3)
+3%
(3)
+17%
(3)
-16%
(2)
+28%
(1)
+43%
(2)
-24%
(2)
-12%
(2)
-33%
(2)
+2%
(3)
-16%
(3)
-1%
(2)
+33%
(3)
-64%
(3)
+4%
1
N/A
0
-64%
(2)
N/A
(2)
+7%
(3)
-56%
(3)
+13%
(2)
+10%
(3)
-20%
(3)
-6%
(3)
-1%
(4)
-34%
(4)
-11%
(6)
-34%
(8)
-30%
(8)
-3%
(7)
+13%
(8)
-20%
(10)
-27%
(10)
+2%
(14)
-37%
(16)
-13%